Spring Bank Pharmaceuticals Nasdaq Listed Banner

Investor Overview

  • Webcast Image Webcast
    Spring Bank to Discuss Inarigivir Data Presented at the International Liver Congress™ (EASL 2019)  (Replay)
    Friday, April 12, 2019 8:00 am EDT
More events are coming soon.

Corporate Profile

Spring Bank is a clinical-stage biopharmaceutical company engaged in the discovery and development of a novel class of therapeutics using its proprietary small molecule nucleic acid hybrid, or SMNH, chemistry platform.
Read more

Upcoming Events

There are currently no events to display.